Statistics for The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease

Total visits

views
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease 442

Total visits per month

views
December 2024 0
January 2025 3
February 2025 3
March 2025 2
April 2025 3
May 2025 9
June 2025 0

File Visits

views
Roberts_2019_Kawasaki.pdf 933
java.util.UUID:40243e7d-3803-4512-a460-b658920929ea 143
java.util.UUID:29d8e21b-6a87-4ae1-8744-f48ccfeb2d0b 35
java.util.UUID:2794c4a9-ea53-4215-9b27-c173e48143a2 9

Top country views

views
United States 221
Germany 112
China 27
United Kingdom 8
Sweden 7
Ukraine 7
South Korea 4
Turkey 3
Canada 2
France 2
Mexico 2
Russia 2
Singapore 2
Austria 1
Switzerland 1
India 1
Kazakhstan 1
Malaysia 1
Saudi Arabia 1

Top city views

views
Kiez 53
Wilmington 53
Gunzenhausen 51
Fairfield 24
Kansas City 18
Houston 14
Shenzhen 11
Ling 10
White Plains 9
Cambridge 8
Nürnberg 8
Kiev 7
Jacksonville 6
Stockholm 6
Washington 6
Ann Arbor 5
San Francisco 5
Atago 3
Beijing 2
Bristol 2
Charlotte 2
Dallas 2
García 2
Indianapolis 2
Jackson 2
Lambeth 2
Ordu 2
Paris 2
Saint Louis 2
Seattle 2
Sejong 2
Singapore 2
Toronto 2
Almaty 1
Bengaluru 1
Birmingham 1
Chicago 1
Clearwater 1
Commack 1
Detroit 1
Falls Church 1
Gilbert 1
Helena 1
Hilliard 1
Istanbul 1
Kista 1
Lake Mary 1
London 1
Matsuyama 1
Moscow 1
New York 1
Osaka 1
Riva 1
Riyadh 1
Saint Petersburg 1
Seremban 1
Tustin 1
Vienna 1
Zürich 1